Multi-cyclic cinnamide derivatives

A compound represented by the formula

• or a pharmacologically acceptable salt thereof, wherein
• Ar1 represents an imidazolyl group that may be substituted with 1 to 3 substituents selected from Substituent Group A1,
• Ar2 represents a phenyl group that may be substituted with 1 to 3 substituents selected from Substituent Group A2,
• X1 represents —CR3═CR4— (wherein R3 and R4 are the same or different and each represent a substituent selected from Substituent Group A3), and
• Het is a 5-membered aromatic heterocyclic group represented by the formula (II):
• wherein Y1 and Y2 are the same or different and each represent a methine group or a carbon atom, an imino group or a nitrogen atom, an oxygen atom, or a sulfur atom, which may be substituted with 1 to 3 substituents selected from the following Substituent Group A4:
• Substituent Group A1:
• (1) a hydrogen atom, (2) a halogen atom, (3) a cyano group, (4) a nitro group, (5) a C3-8 cycloalkyl group, (6) a C2-6 alkenyl group, (7) a C2-6 alkynyl group, (8) a C1-6 alkoxy group, (9) a C3-8 cycloalkoxy group, (10) a formyl group, (11) a C1-6 alkylcarbonyl group and (12) a C1-6 alkyl group (wherein the C1-6 alkyl group may be substituted with 1 to 3 substituents selected from the group consisting of a halogen atom, a hydroxyl group, a cyano group, a C1-6 alkoxy group, a C3-8 cycloalkyl group and a C1-6 alkylcarbonyl group);
• Substituent Group A2:
• (1) a hydrogen atom, (2) a halogen atom, (3) a hydroxyl group, (4) a cyano group, (5) a C1-6 alkoxy group (wherein the C1-6 alkoxy group may be substituted with 1 to 3 substituents selected from the group consisting of a halogen atom, a cyano group, a C1-6 alkyl group, a C2-6 alkenyl group, a C2-6 alkynyl group and a C3-8 cycloalkyl group), (6) a C3-8 cycloalkoxy group, (7) a C2-6 alkenyloxy group and (8) a C2-6 alkynyloxy group;
• Substituent Group A3:
• (1) a hydrogen atom, (2) a halogen atom, (3) A* (wherein A* represents an aromatic hydrocarbon ring selected from selected from phenyl group, indenyl group, naphthyl group, azulenyl group, heptalenyl group, biphenyl group, fluorenyl group, phenalenyl group, phenanthrenyl group, anthracenyl group, an aromatic heterocycle selected from a pyrrolyl group, a pyridyl group, a pyridazinyl group, a pyrimidinyl group, a pyrazinyl group, a pyrazolinyl group, an imidazolyl group, an indolyl group, an isoindolyl group, an indolizinyl group, a purinyl group, an indazolyl group, a quinolyl group, an isoquinolyl group, a quinolizinyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a pteridinyl group, an imidazotriazinyl group, a pyrazinopyridazinyl group, an acridinyl group, a phenanthridinyl group, a carbazolyl group, a perimidinyl group, a phenanthrolinyl group, a thienyl group and a benzothienyl group, a furyl group, a pyranyl group, a cyclopentapyranyl group, a benzofuranyl group and an isobenzofuranyl group, a thiazolyl group, an isothiazolyl group, a benzothiazolinyl group, a benzothiadiazolyl group, a phenothiazinyl group, an isoxazolyl group, a furazanyl group, a phenoxazinyl group, a pyrazoloxazolyl group, an imidazothiazolyl group, a thienofuryl group, a furopyrrolyl group and a pyridooxazinyl group), that may be substituted with 1 to 3 substituents selected from Substituent Group A5, (4) a C1-6 alkyl group (wherein the C1-6 alkyl group may be substituted with 1 to 3 substituents selected from the group consisting of a formyl group, a halogen atom, a hydroxyl group, a hydroxyl group having a protecting group, a cyano group, a C2-6 alkenyl group, a C2-6 alkynyl group, a C3-8 cycloalkyl group, a C1-6 alkoxy group, a C1-6 alkylthio group, a C1-6 alkylsulfinyl group, a C1-6 alkylsulfonyl group, a C1-6 alkylcarbonyl group, an amino group (wherein the amino group may be substituted with 1 to 2 of a C1-6 alkyl group optionally having 1 to 3 halogen atoms), A* (wherein A* is as defined above) that may be substituted with 1 to 3 substituents selected from Substituent Group A5, a 6- to 14-membered non-aromatic hydrocarbon ring that may be substituted with 1 to 3 substituents selected from Substituent Group A5, a 5- to 14-membered non-aromatic heterocycle that may be substituted with 1 to 3 substituents selected from Substituent Group A5, and —X-A* (wherein X represents an imino group, —O— or —S—, and A* is as defined above that may be substituted with 1 to 3 substituents selected from Substituent Group A5)) and (5) a C1-6 alkoxy group that may be substituted with 1 to 3 halogen atoms;
• Substituent Group A4:
• (1) a hydrogen atom, (2) a halogen atom, (3) a hydroxyl group, (4) a cyano group, (5) a nitro group, (6) a C3-8 cycloalkyl group, (7) a C2-6 alkenyl group that may be substituted with 1 to 3 substituents selected from Substituent Group A5, (8) a C2-6 alkynyl group that may be substituted with 1 to 3 substituents selected from Substituent Group A5, (9) a C3-8 cycloalkoxy group, (10) a C3-8 cycloalkylthio group, (11) a formyl group, (12) a C1-6 alkylcarbonyl group that may be substituted with 1 to 3 substituents selected from Substituent Group A5, (13) a C1-6 alkylthio group that may be substituted with 1 to 3 substituents selected from Substituent Group A5, (14) a C1-6 alkylsulfinyl group that may be substituted with 1 to 3 substituents selected from Substituent Group A5, (15) a C1-6 alkylsulfonyl group that may be substituted with 1 to 3 substituents selected from Substituent Group A5, (16) a hydroxyimino group, (17) a C1-6 alkoxyimino group, (18) a C1-6 alkyl group that may be substituted with 1 to 3 substituents selected from Substituent Group A5, (19) a C1-6 alkoxy group that may be substituted with 1 to 3 substituents selected from Substituent Group A5, (20) an amino group that may be substituted with 1 or 2 substituents selected from Substituent Group A5, (21) a carbamoyl group that may be substituted with 1 or 2 substituents selected from Substituent Group A5, (22) A* (wherein A* is as defined above) that may be substituted with 1 to 3 substituents selected from Substituent Group A5, (23) a 6- to 14-membered non-aromatic hydrocarbon ring that may be substituted with 1 to 3 substituents selected from Substituent Group A5, (24) a 5- to 14-membered non-aromatic heterocycle that may be substituted with 1 to 3 substituents selected from Substituent Group A5, (25) a C2-6 alkenyloxy group, (26) a C2-6 alkynyloxy group, (27) a C3-8 cycloalkylsulfinyl group, (28) a C3-8 cycloalkylsulfonyl group, (29) —X-A* (wherein X represents an imino group, —O— or —S—, and A* is as defined above that may be substituted with 1 to 3 substituents selected from Substituent Group A6), (30) —CO-A* (wherein A* is as defined above), (31) ═CH-A* (wherein A* is as defined above), (32) a carboxyl group and (33) a C1-6 alkoxycarbonyl group;
• Substituent Group A5:
• (1) a hydrogen atom, (2) a halogen atom, (3) a hydroxyl group, (4) a cyano group, (5) a nitro group, (6) a C3-8 cycloalkyl group, (7) a C2-6 alkenyl group, (8) a C2-6 alkynyl group, (9) a C3-8 cycloalkoxy group, (10) a C3-8 cycloalkylthio group, (11) a formyl group, (12) a C1-6 alkylcarbonyl group, (13) a C1-6 alkylthio group, (14) a C1-6 alkylsulfinyl group, (15) a C1-6 alkylsulfonyl group, (16) a hydroxyimino group, (17) a C1-6 alkoxyimino group, (18) a C1-6 alkyl group (wherein the C1-6 alkyl group may be substituted with 1 to 3 substituents selected from Substituent Group A6, A* (wherein A* is as defined above that may be substituted with 1 to 3 substituents selected from Substituent Group A6), (19) a C1-6 alkoxy group (wherein the C1-6 alkoxy group may be substituted with 1 to 3 substituents selected from Substituent Group A6, A* (wherein A* is as defined above that may be substituted with 1 to 3 substituents selected from Substituent Group A6), (20) an amino group that may be substituted with 1 or 2 C1-6 alkyl groups, (21) a carbamoyl group that may be substituted with 1 or 2 C1-6 alkyl groups, (22) A* (wherein A* is as defined above) that may be substituted with 1 to 3 substituents selected from Substituent Group A6, (23) a 6- to 14-membered non-aromatic hydrocarbon ring that may be substituted with 1 to 3 substituents selected from Substituent Group A6, (24) a 5- to 14-membered non-aromatic heterocycle that may be substituted with 1 to 3 substituents selected from Substituent Group A6, (25) a C2-6 alkenyloxy group, (26) a C2-6 alkynyloxy group, (27) a C3-8 cycloalkylsulfinyl group, (28) a C3-8 cycloalkylsulfonyl group, (29) —X-A* (wherein X represents an imino group, —O— or —S—, and A* is as defined above that may be substituted with 1 to 3 substituents that may be substituted with 1 to 3 substituents selected from Substituent Group A6), (30) —CO-A* (wherein A* is as defined above) and (31) ═CH-A (wherein A* is as defined above);
• Substituent Group A6:
• (1) a hydrogen atom, (2) a halogen atom, (3) a hydroxyl group, (4) a cyano group, (5) an amino group that may be substituted with 1 or 2 C1-6 alkyl groups, (6) a C1-6 alkyl group (wherein the C1-6 alkyl group may be substituted with 1 to 3 substituents selected from the group consisting of a halogen atom, a hydroxyl group, a cyano group, an amino group that may be substituted with 1 or 2 C1-6 alkyl groups) and (7) a C1-6 alkoxy group (wherein the C1-6 alkoxy group may be substituted with 1 to 3 substituents selected from the group consisting of a halogen atom, a hydroxyl group, a cyano group, an amino group that may be substituted with 1 or 2 C1-6 alkyl groups).